Back to Journals » Patient Preference and Adherence » Volume 7

Predictors of nonadherence with blood pressure regimens in hemodialysis

Authors Kauric-Klein Z

Received 18 March 2013

Accepted for publication 23 August 2013

Published 23 September 2013 Volume 2013:7 Pages 973—980

DOI https://doi.org/10.2147/PPA.S45369

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 3

Zorica Kauric-Klein

College of Nursing, Wayne State University, Detroit, MI, USA

Background: Hypertension is very poorly controlled in patients on hemodialysis (HD). Demographic and psychosocial predictors of nonadherence with blood pressure (BP) regimens in HD have not been investigated. A study of 118 HD patients from six outpatient HD units was conducted to determine the relationship between demographic/psychosocial factors and adherence with BP-related regimens, ie, fluid restriction, BP medication adherence, and HD treatment adherence.
Methods: Descriptive statistics, Pearson correlations, and multiple regressions were conducted to analyze and determine the relationships between variables.
Results: Younger age was related to increased fluid gains (r = -0.37, P < 0.01), decreased medication adherence (r = -0.19, P = 0.04), increased missed HD treatments (r = -0.37, P < 0.01), and diastolic BP (r = -0.60, P < 0.01). Female sex was significantly related to decreased fluid gains (r = -0.28, P < 0.01). Race was related to increased missed HD treatments (r = 0.22, P = 0.02). Increased social support was related to decreased missed HD treatments (r = -0.22, P = 0.02). Depression scores were inversely related to decreased medication adherence scores (r = 0.24, P = 0.01).
Conclusion: By identifying risk factors for nonadherence with BP-related regimens (young age, male sex, decreased social support, and depression), health care providers can plan early clinical intervention to minimize the risk of nonadherence.

Keywords: nonadherence, hemodialysis, blood pressure, demographic predictors, psychosocial predictors

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Readers of this article also read:

Emerging and future therapies for hemophilia

Carr ME, Tortella BJ

Journal of Blood Medicine 2015, 6:245-255

Published Date: 3 September 2015

Green synthesis of water-soluble nontoxic polymeric nanocomposites containing silver nanoparticles

Prozorova GF, Pozdnyakov AS, Kuznetsova NP, Korzhova SA, Emel’yanov AI, Ermakova TG, Fadeeva TV, Sosedova LM

International Journal of Nanomedicine 2014, 9:1883-1889

Published Date: 16 April 2014

Methacrylic-based nanogels for the pH-sensitive delivery of 5-Fluorouracil in the colon

Ashwanikumar N, Kumar NA, Nair SA, Kumar GS

International Journal of Nanomedicine 2012, 7:5769-5779

Published Date: 15 November 2012

A novel preparation method for silicone oil nanoemulsions and its application for coating hair with silicone

Hu Z, Liao M, Chen Y, Cai Y, Meng L, Liu Y, Lv N, Liu Z, Yuan W

International Journal of Nanomedicine 2012, 7:5719-5724

Published Date: 12 November 2012

Cross-linked acrylic hydrogel for the controlled delivery of hydrophobic drugs in cancer therapy

Deepa G, Thulasidasan AK, Anto RJ, Pillai JJ, Kumar GS

International Journal of Nanomedicine 2012, 7:4077-4088

Published Date: 27 July 2012

Crystallization after intravitreal ganciclovir injection

Pitipol Choopong, Nattaporn Tesavibul, Nattawut Rodanant

Clinical Ophthalmology 2010, 4:709-711

Published Date: 14 July 2010